Everything you need to know about Gaudium IVF and Women Health IPO

About

Gaudium IVF and Women Health Limited is a public limited company incorporated on March 24, 2015, originally as Gaudium IVF and Women Health Private Limited. The Company was converted into a public limited entity on October 24, 2024. Its registered office is located in Janak Puri, New Delhi, India. The Company was founded by its Promoter, Dr Manika Khanna, and is promoted by Dr Manika Khanna, Dr Peeyush Khanna and Vishad Khanna . Gaudium IVF operates in the assisted reproductive technology (ART) segment, providing fertility treatments such as In Vitro Fertilisation (IVF), Intracytoplasmic Sperm Injection (ICSI), and Intrauterine Insemination (IUI). It has expanded across multiple states through a hub-and-spoke model and operates 30+ locations, comprising 7 hubs and 28 spokes. Its business model focuses on specialised fertility services delivered through standardised clinical protocols and stage-wise treatment processes. The Company’s strengths include strong promoter-led clinical expertise, an expanding multi-location network, and its positioning within India’s growing IVF and fertility services market.

IPO schedule

Issue open date 2026-02-20
Issue close date 2026-02-24
UPI mandate deadline 2026-02-24 (5 PM)
Allotment finalization 2026-02-25
Refund initiation 2026-02-26
Share credit 2026-02-26
Listing date 2026-02-27
Mandate end date 2026-03-11
Lock-in end date for anchor investors (50%) 2026-03-27
Lock-in end date for anchor investors (remaining) 2026-05-26

Financials

Financial Year Ended March 2024 March 2025 September 2025
Total Assets 51.01 88.51 106.62
Revenue 48.15 70.96 49.75
Profit After Tax 10.32 19.13 12.51

Issue size

Funds Raised in the IPO Amount
Total issue size 165
Fresh Issue - Proceeds go to the company 90
Offer for sale - Proceeds go to the existing investors 75

Utilisation of proceeds

Purpose INR crores (%)
Establishment of New IVF Centers (Capital Expenditure) 50 (55.56%)
Repayment / Pre-payment of Outstanding Loans 20 (22.22%)
General corporate purposes 20 (22.22%)

Strengths

  • Established IVF-focused brand founded by experienced specialist Dr. Manika Khanna.
  • Pan-India presence with 30+ locations under a scalable hub-and-spoke model.
  • Comprehensive fertility portfolio including IVF, ICSI and IUI treatments.
  • Strong revenue growth and improving profitability in recent years.
  • Positioned in a fast-growing Indian IVF market with high projected growth.

Risks

  • High contingent liabilities relative to net worth.
  • Exposure to operational and legal risks inherent in healthcare services.
  • High employee attrition and dependence on skilled doctors and embryologists.
  • Significant dependence on promoters for leadership and brand value.
  • Past negative cash flows and rising borrowings are impacting financial flexibility

Allotment Status for Gaudium IVF and Women Health

To check your IPO allotment status:

  • Visit the Bigshare Services IPO Application Status page.
  • Select the company name from the dropdown menu.
  • Select and enter one of the following: PAN, Application Number, DP/Client ID, or Account Number/IFSC.
  • Click Submit to view your allotment status